There is little time left for Privia Health Group Inc (PRVA) to reach its 1-year target estimate. How soon will it surpass it?

Privia Health Group Inc (NASDAQ:PRVA) shares traded 0.87% higher at $22.11 on Wall Street last session.

PRVA stock price is now -4.47% away from the 50-day moving average and 1.25% away from the 200-day moving average. The market capitalization of the company currently stands at $2.70B.

With the price target of $25, Needham recently initiated with Buy rating for Privia Health Group Inc (NASDAQ: PRVA). , while ‘KeyBanc Capital Markets’ rates the stock as ‘Overweight’

In other news, Mehrotra Parth, Chief Executive Officer sold 15,909 shares of the company’s stock on May 13 ’25. The stock was sold for $390,089 at an average price of $24.52. Upon completion of the transaction, the Chief Executive Officer now directly owns 407,234 shares in the company, valued at $9.0 million. An SEC document containing details of the transaction can be found on the SEC’s website. On May 12 ’25, Chief Executive Officer Mehrotra Parth sold 13,773 shares of the business’s stock. A total of $344,187 was realized by selling the stock at an average price of $24.99. This leaves the insider owning 423,143 shares of the company worth $9.36 million. A total of 11.45% of the company’s stock is owned by insiders.

During the past 12 months, Privia Health Group Inc has had a low of $16.47 and a high of $26.09. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 1.88, and a quick ratio of 1.88. According to the stock market information, the enterprise value for the company is $2390342656, which is based on a 178.88 price-to-earnings ratio, a 2.91 price-to-earnings-growth ratio, and a beta of 0.83. The fifty day moving average price for PRVA is $23.1456 and a two-hundred day moving average price translates $21.83785 for the stock.

The latest earnings results from Privia Health Group Inc (NASDAQ: PRVA) was released for 2025-03-31. The net profit margin was 0.87% and return on equity was 2.53% for PRVA. The company reported revenue of $480.1 million for the quarter, compared to $415.24 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 15.62 percent.

Related Posts

Fosters Research
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.